Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04794595

Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children

Clinical Features and Outcomes of Continuous Blood Purification Versus Non-continuous Blood Purification in Pediatric Patients With Sepsis or Septic Shock

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Children's Hospital of Fudan University · Academic / Other
Sex
All
Age
28 Days – 18 Years
Healthy volunteers
Not accepted

Summary

The effect of continuous blood purification (CBP) in children is unclear. Also, the timing of early application is still being explored. In this study, we need to explore the efficacy and the timing of application of CBP in children with sepsis or septic shock.

Detailed description

Early intervention of CBP can remove inflammatory factors in patients with sepsis and reduce the damage of inflammatory factors to organs; at the same time, it can also promote the body's immune response, significantly improve immune dysfunction, and restore the body's immune balance. However, the timing of early application of CBP in childhood sepsis is still unclear. Therefore, it is necessary to further explore the treatment and prognosis of this technology in the early treatment of sepsis.

Conditions

Interventions

TypeNameDescription
PROCEDURECBPcontinuous blood purification can prevent or treat fluid overload in children with septic shock or other sepsis-associated organ dysfunction who are unresponsive to fluid restriction and diuretic therapy management of septic AKI patients, particularly those with hemodynamic instability or fluid overload. Also, it can remove cytokines

Timeline

Start date
2020-12-01
Primary completion
2026-12-30
Completion
2026-12-30
First posted
2021-03-12
Last updated
2026-03-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04794595. Inclusion in this directory is not an endorsement.